Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Comparison of the association with sleep apnoea of obesity versus insulin resistance Source: Eur Respir J 2015; 46: 1829-1832 Year: 2015
Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Obstructive sleep apnoea is associated with decreased insulin sensitivity in females Source: Eur Respir J 2008; 31: 1054-1060 Year: 2008
Sleep, sleep-disordered breathing and metabolic consequences Source: Eur Respir J 2009; 34: 243-260 Year: 2009
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults? Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003
Sleep apnoea, insulin resistance and diabetes: the first step is in the fat Source: Eur Respir J , 49 (4) 1700179; DOI: 10.1183/13993003.00179-2017 Year: 2017
Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006
The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019
Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Insulin resistance in obstructive sleep apnea patients Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea Source: Eur Respir J 2012; 39: 1136-1143 Year: 2012
Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003